Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

Stock Information for Oncocyte Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oncocyte Corporation

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Oncocyte Expands Market Opportunity for VitaGraft(TM) Kidney
Oncocyte to Participate in "J.P. Morgan Week" and Host Investor Meetings
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.